The high prevalence of cigarette smoking in patients with respiratory disease puts them at risk of developing clinically important drug interactions. Cigarette smoking reduces the therapeutic response to certain drugs such as theophyllines through the induction of hepatic cytochrome P450 isoenzymes. Smokers with asthma and patients with COPD have reduced sensitivity to corticosteroids, possibly due to non-eosinophilic airway inflammation, altered glucocorticoid receptor activity or reduced histone deacetylase activity. Although all smokers should be encouraged to stop smoking, there is limited information on the influence of smoking cessation on the therapeutic and anti-inflammatory effects of a number of the drugs used in the treatment of respiratory disease.
ATS/ERS ( 2002) American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This Joint Statement of the ATS, and the ERS was adopted by the ATS Board of Directors, June 2001 and by The ERS Executive Committee, June 2001. Am J Respir Crit Care Med 165, 277-304.
2.
Alsaeedi, A., Sin, D.D. and McAlister, F.A. (2002) The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials. Am J Med113: 59-65.
3.
Antoniou, K.M., Hansell, D.M., Rubens, M.B., Marten, K., Desai, S.R., Siafakas, N.M. et al. (2008) Idiopathic Pulmonary Fibrosis: Outcome in Relation to Smoking Status. Am J Respir Crit Care Med177: 190-194.
4.
BTS (2003) British Thoracic Society and Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax58: i1-i94.
5.
Bacci, E., Cianchetti, S., Bartoli, M., Dente, F.L., Di Franco, A., Vagaggini, B. et al. (2006) Low Sputum Eosinophils Predict the Lack of Response to Beclomethasone in Symptomatic Asthmatic Patients. Chest129: 565-572.
6.
Barnes, N.C., Qiu, Y.-S., Pavord, I.D., Parker, D., Davis, P.A., Zhu, J. et al. (2006) Antiinflammatory Effects of Salmeterol/Fluticasone Propionate in Chronic Obstructive Lung Disease. Am J Resp Crit Care Med173: 736-743.
7.
Barnes, P., Pedersen, S. and Busse, W. (1998) Efficacy and Safety of Inhaled Corticosteroids. New Developments. Am J Respir Crit Care Med157: S1-53.
8.
Barnes, P.J. (2004) Corticosteroid Resistance in Airway Disease. Proc Am Thorac Soc1: 264-268.
9.
Boulet, L.-P., Lemiere, C., Archambault, F., Carrier, G., Descary, M.C. and Deschesnes, F. (2006) Smoking and Asthma: Clinical and Radiologic Features, Lung Function, and Airway Inflammation. Chest129: 661-668.
10.
Bourbeau, J., Christodoulopoulos, P., Maltais, F., Yamauchi, Y., Olivenstein, R. and Hamid, Q. (2007) Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial. Thorax62: 938-943.
11.
Brightling, C.E., McKenna, S., Hargadon, B., Birring, S., Green, R., Siva, R. et al. (2005) Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease. Thorax60: 193-198.
12.
Bukowskyj, A., Nakatsu, K. and Munt, P. (1984) Theophylline Reassessed. Annals of Internal Medicine101: 63-73.
13.
Burge, P., Calverley, P.M.A., Jones, P.W., Spencer, S. and Anderson, J. (2003) Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study. Thorax58: 654-658.
14.
CDC (2006) Fact Sheet: Adult cigarette smoking in the United States: Current estimates. Smoking and Tobacco Use. Available online at: http://www.cdc.gov/tobacco/data_statistics/Factsheets/adult_cig_smoking.html (retrieved 12th December 2007 ).
15.
Calverley, P.M.A., Anderson, J.A., Celli, B., Ferguson, G.T., Jenkins, C., Jones, P.W. et al. (2007a) Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease. In N Eng J Med, pp. 775-789.
16.
Calverley, P.M.A., Sanchez-Toril, F., McIvor, A., Teichmann, P., Bredenbroeker, D. and Fabbri, L.M. (2007b) Effect of 1-Year Treatment with Roflumilast in Severe Chronic Obstructive Pulmonary Disease. Am J Resp Crit Care Med176: 154-161.
17.
Calverley, P., Pauwels, R., Vestbo, J., Jones, P., Pride, N., Gulsvik, A. et al. (2003a) Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. The Lancet361: 449-456.
18.
Calverley, P.M., Boonsawat, W., Cseke, Z., Zhong, N., Peterson, S. and Olsson, H. (2003b) Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease. Eur Resp J22: 912-919.
19.
Caminati, A. and Harari, S. (2006) Smoking-related Interstitial Pneumonias and Pulmonary Langerhans Cell Histiocytosis. Proc Am Thorac Soc3: 299-306.
20.
Cerveri, I., Accordini, S., Corsico, A., Zoia, M., Carrozzi, L., Cazzoletti, L. et al. (2003) Chronic cough and phlegm in young adults . Eur Respir J22: 413-417.
21.
Chalmers, G., MacLeod, K., Thomson, L., Little, S., McSharry, C. and Thomson, N.C. (2001) Smoking and airway inflammation in patients with mild asthma. Chest120: 1917-1922.
22.
Chalmers, G.W., Macleod, K.J., Little, S.A., Thomson, L.J., McSharry, C.P. and Thomson, N.C. (2002) Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax57: 226-230.
23.
Chanez, P., Bourdin, A., Vachier, I., Godard, P., Bousquet, J. and Vignola, A.M. (2004) Effects of Inhaled Corticosteroids on Pathology in Asthma and Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc1: 184-190.
24.
Chaudhuri, R., Livingston, E., McMahon, A.D., Lafferty, J., Fraser, I., Spears, M. et al. (2006) Effects of Smoking Cessation on Lung Function and Airway Inflammation in Smokers with Asthma. Am J Respir Crit Care Med174: 127-133.
25.
Chaudhuri, R., Livingston, E., McMahon, A.D., Thomson, L., Borland, W. and Thomson, N.C. (2003) Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med168: 1308-1311.
26.
Cipolle, R., Seifert, R., Neilan, B., Zaske, D.E. and Haus, E. (1981) Heparin kinetics: variables related to deposition and dosage. Clin Pharmacol Ther29: 387-393.
Cosio, B.G., Mann, B., Ito, K., Jazrawi, E., Barnes, P.J., Chung, K.F. et al. (2004a) Histone Acetylase and Deacetylase Activity in Alveolar Macrophages and Blood Monocytes in Asthma. Am J Respir Crit Care Med170: 141-147.
29.
Cosio, B.G., Tsaprouni, L., Ito, K., Jazrawi, E., Adcock, I.M. and Barnes, P.J. (2004b) Theophylline Restores Histone Deacetylase Activity and Steroid Responses in COPD Macrophages. J Exp Med200: 689-695.
30.
Culpitt, S.V., Rogers, D.F., Shah, P., De Matos, C., Russell, R.E.K., Donnelly, L.E. et al. (2003) Impaired Inhibition by Dexamethasone of Cytokine Release by Alveolar Macrophages from Patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med167: 24-31.
31.
Dijkstra, A., Vonk, J.M., Jongepier, H., Koppelman, G.H., Schouten, J.P., ten Hacken, N.H.T., et al. (2006) Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex. Thorax61: 105-110.
32.
Doll, R., Peto, R., Boreham, J. and Sutherland, I. (2004) Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ328: 1519-1528.
33.
Ducharme, F., Lasserson, T. and Cates, C. (2006) Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. Cochrane Database Syst Rev.2006 Oct 18;(4):CD003137. 18, CD003137.
34.
Faber, M.S. and Fuhr, U. (2004) Time response of cytochrome P450 1A2 activity on cessation of heavy smoking. Clin Pharmacol Ther76: 178-184.
35.
Franchimont, D., Martens, H., Hagelstein, M.T., Louis, E., Dewe, W., Chrousos, G.P. et al. (1999) Tumor Necrosis Factor {alpha} Decreases, and Interleukin-10 Increases, the Sensitivity of Human Monocytes to Dexamethasone: Potential Regulation of the Glucocorticoid Receptor. J Clin Endocrinol Metab84: 2834-2839.
36.
GINA Report (2006) Global Strategy for Asthma Management and Prevention. In http://www.ginasthma.com/Guideline (retrieved 12th December 2007).
37.
Galan, I., Rodriguez-Artalejo, F., Diez-Ganan, L., Tobias, A., Zorrilla, B. and Garndarillas, A. (2006) Clustering of behavioural risk factors and compliance with clinical preventive recommendations in Spain . Preventive Medicine42: 343-347.
38.
Gan, W., Man, S. and Sin, D. (2005) BMC Pulm Med.2005 Feb 11;5:3. BMC Pulm Med.2005 Feb 11;5:35: 3.
39.
Halterman, J.S., Szilagyi, P.G.,Yoos, H.L., Conn, K.M., Kaczorowski, J.M., Holzhauer, R.J. et al. (2004) Benefits of a School-Based Asthma Treatment Program in the Absence of Secondhand Smoke Exposure: Results of a Randomized Clinical Trial. Arch Pediatr Adolesc Med158: 460-467.
40.
Hawrylowicz, C., Richards, D., Loke, T.K., Christopher Corrigan, C. and Lee, T. (2002) A defect in corticosteroid-induced IL-10 production in, Tlymphocytes from corticosteroid-resistant patients. J Allergy Clin Immunol109: 369-370.
41.
Hodge, S., Hodge, G., Brozyna, S., Jersmann, H., Holmes, M. and Reynolds, P.N. (2006) Azithromycin sincreases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages. Eur Respir J28: 486-495.
42.
IPF (2000) (Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment). International Consensus Statement. Am J Respir Crit Care Med161: 646-664.
43.
Ilowite, J., Bennett, W., Sheetz, M., Groth, M. and Nierman, D. (1988) Permeability of the bronchial mucosa to 99m Tc-DTPA in asthma. Am Rev Resp Dis139: 1139-1143.
44.
Invernizzi, G., Ruprecht, A., Paredi, P., Fornasari, W., Mazza, R., Barnes, P. et al. (2004) Particle size of dry powder fluticasone is modified in the presence of tobacco smoke. Eur Respir J34: 28s.
45.
Irusen, E., Matthews, J., Takahashi, A., Barnes, P., Chung, K. and Adcock, I. (2002) p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: Role in steroid-insensitive asthma. J Allergy Clin Immunol109: 649-657.
46.
Ito, K., Lim, S., Caramori, G., Chung, K., Barnes, P. and Adcock, I. (2001) Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. FASEB J15: 1110-1112.
47.
Jang, A.S., Lee, J.H., Park, S.W., Lee, Y.M., Uh, S.T., Kim, Y.H. et al. (2005) Factors Influencing the Responsiveness to Inhaled Glucocorticoids of Patients With Moderate-to-Severe Asthma. Chest128: 1140-1145.
48.
Jenne, J., Nagasawa, H., McHugh, R., MacDonald, F. and Wyse, E. (1975) Decreased theophylline half-life in cigarette smokers . Life Sciences17: 195-198.
49.
Jusko, W., Schentag, J., Clark, J., Gardner, M. and Yurchak, A. (1978) Enhanced biotransformation of theophylline in marijuana and tobacco smokers. Clin Pharmacol Ther24: 405-410.
50.
Kam, J., Szefler, S., Surs, W., Sher, E. and Leung, D. (1993) Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and, T cell response to Glucocorticoids. J Immunol151: 3460-3466.
51.
Keatings, V., Jatakanon, A., Worsdell,Y. and Barnes, P. (1997) Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med155: 542-548.
52.
Kennedy, S., Elwood, R., Wiggs, B., Pare, P. and Hogg, J. (1984) Increased airway mucosal permeability of smokers: relationship to airway reactivity. Am Rev Resp Dis129: 143-148.
53.
Kerstjen, H., Schouten, J., Brand, P., Schoonbrood, D., Sterk, P. and Postma, D. (1995) Importance of total serum IgE for improvement in airways hyperresponsiveness with inhaled corticosteroids in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med151: 360-368.
54.
Kharitonov, S.B.P. (2003) Nitric oxide, nitrotyrosine, and nitric oxide modulators in asthma and chronic obstructive pulmonary disease. Current Allergy Asthma Reports3: 121-129.
55.
Kroon, L. (2007) Drug interactions with smoking. Am J Health-Syst Pharm64: 1917-1921.
56.
Lange, P., Parner, J., Vestbo, J., Schnohr, P. and Jensen, G. (1998) A 15 year follow-up study of ventilatory function in adults with asthma. N Engl J Med339: 1194-1200.
57.
Lange, P., Scharling, H., Ulrik, C.S. and Vestbo, J. (2006) Inhaled corticosteroids and decline of lung function in community residents with asthma. Thorax61: 100-104.
58.
Lazarus, S.C., Chinchilli, V.M., Rollings, N.J., Boushey, H.A., Cherniack, R., Craig, T.J. et al. (2007) Smoking Affects Response to Inhaled Corticosteroids or Leukotriene Receptor Antagonists in Asthma. Am J Respir Crit Care Med175: 783-790.
59.
Lee Hand, W., Boozer, R. and King-Thompson, N. (1985) Antibiotic uptake by alveolar macrophages of smokers. Antimicrobial Agents and Chemotherapy27: 42-45.
60.
Lee, B., Benowitz, N. and Jacob, P. (1987) Cigarette abstinence, nicotine gum and theophylline disposition. Ann Intern Med106: 535-555.
61.
Leung, D. and Bloom, J. (2003) Update on glucocorticoid action and resistance . J Allergy Clin Immunol111: 3-22.
62.
Lewis-Tuffin, L.J. and Cidlowski, J.A. (2006) The Physiology of Human Glucocorticoid Receptor β (hGRβ) and Glucocorticoid Resistance. Ann NY Acad Sci1069: 1-9.
63.
Little, S., Chalmers, G., MacLeod, K., McSharry, C. and Thomson, N. (2000) Non-invasive markers of airway inflammation as predictors of oral steroid responsiveness in asthma. Thorax53: 232-234.
64.
Livingston, E., Chaudhuri, R., McMahon, A.D., Fraser, I., McSharry, C.P. and Thomson, N.C. (2007) Systemic sensitivity to corticosteroids in smokers with asthma. Eur Respir J29: 64-71.
65.
Livingston, E., Darroch, C., Chaudhuri, R., McPhee, I., McMahon, A., MacKenzie, S. et al. (2004) Glucocorticoid receptor alpha to beta ratio in blood mononuclear cells is reduced in cigarette smokers. J Allergy Clin Immunol114: 1475-1478.
66.
Livingston, E., Thomson, N. and Chalmers, G. (2005) Impact of smoking on asthma therapy: a critical review of clinical evidence. Drugs65: 1521-1536.
67.
Mannino, D.M. and Buist, A.S. (2007) Global burden of COPD: risk factors, prevalence, and future trends. Lancet370: 765-773.
68.
Matsunga, S., Plezia, P., Karol, M., Camilli, A. and Benowitz, N. (1989) Effects of passive smoking on theophylline clearance . Clin Pharmacol Therapeutics46: 399-407.
69.
Mayo, P. (2001) Effect of passive smoking on theophylline clearance in children. Ther Drug Monit23: 503-505.
70.
Mochida-Nishimura, K., Surewicz, K., Cross, J., Hejal, R., Templeton, D., Rich, E. et al. (2001) Differential activation of MAP kinase signalling pathways and nuclear factor-kappaB in bronchoalveolar cells of smokers and nonsmokers. Mol Med7: 177-185.
71.
Moita, J., Barbara, C., Cardoso, J., Costa, R., Sousa, M., Ruiz, J. et al. (2008) Tiotropium improves FEV1 in patients with COPD irrespective of smoking status. Pulm Pharmacol Ther21(1):146-151.
72.
Montelukast Asthmatic Smoker Study (2006) Available online at: http://www.clinicaltrials.gov/ct/show/NCT00284856?order=6. (retrieved 12th December 2007).
73.
Murdoch, R., Zussman, B., Schofield, J. and Webber, D. (2004) Lack of pharmacokinetic interactions between cilomilast and theophylline or smoking in healthy volunteers. J Clin Pharmacol44: 1046-1053.
74.
Niewoehner, D.E., Rice, K., Cote, C., Paulson, D., Cooper, Jr. J.A.D., Korducki, L. et al. (2005) Prevention of Exacerbations of Chronic Obstructive Pulmonary Disease with Tiotropium, a Once-Daily Inhaled Anticholinergic Bronchodilator: A Randomized Trial. Ann Intern Med143: 317-326.
75.
Pacifici, G., De Santi, C., Mussi, A. and Ageletti, C. (1996) Interindividual variability in the rate of salbutmol sulphation in the human lung. Eur J Clin Pharmacol49: 299-303.
76.
Paramothayan, S. and Jones, P.W. (2002) Corticosteroid Therapy in Pulmonary Sarcoidosis: A Systematic Review. JAMA287: 1301-1307.
77.
Pedersen, B., Dahl, R., Karlstrom, R., Peterson, C. and Venge, P. (1996) Eosinophil and neutrophil activity in asthma in one-year trial with inhaled budesonide. Am J Respir Crit Care Med153: 1519-1529.
78.
Pedersen, S.E., Bateman, E.D., Bousquet, J., Busse, W.W., Yoxall, S. and Clark, T.J. (2007) Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma control study. J Allergy Clin Immunol120: 1036-1042.
79.
Pfeifer, H. and Greenblatt, D. (1978) Clinical Toxicity of theophylline in relation to cigarette smoking. A report from the Boston Collaborative Drug Surveillance Program Chest4: 455-459.
80.
Rabe, K.F., Bateman, E.D., O'Donnell, D., Witte, S., Bredenbroker, D. and Bethke, T.D. (2005) Roflumilast-an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial. Lancet366: 563-571.
81.
Renda, T., Baraldo, S., Pelaia, G., Bazzan, E., Turato, G., Papi, A. et al. (2008) Increased activation of p38 MAPK in COPD . Eur Respir J31: 62-69.
82.
Rennard, S., Serby, C., Ghafouri, M., Johnson, P. and Friedman, M. (1996) Extended therapy with ipratropium is associated with improved lung function in patients with COPD. A retrospective analysis of data from seven clinical trials. Chest110: 62-70.
83.
Rennard, S.I., Schachter, N., Strek, M., Rickard, K. and Amit, O. (2006) Cilomilast for COPD: Results of a 6-Month, Placebo-Controlled Study of a Potent, Selective Inhibitor of Phosphodiesterase 4. Chest129: 56-66.
84.
Rudd, R.M., Prescott, R.J., Chalmers, J.C., Johnston, I.D.A. for the Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic, S. (2007) British Thoracic Society Study on cryptogenic fibrosing alveolitis: response to treatment and survival. Thorax62: 62-66.
85.
Schachter, E. (2006) Cilomilast. Drugs of Today42: 237-247.
86.
Silverman, R.A., Boudreaux, E.D., Woodruff, P.G., Clark, S. and Camargo, Jr. C.A. , (2003) Cigarette Smoking Among Asthmatic Adults Presenting to 64 Emergency Departments. Chest123: 1472-1479.
87.
Sin, D.D., Wu, L., Anderson, J.A., Anthonisen, N.R., Buist, A.S., Burge, P.S. et al. (2005) Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax60: 992-997.
88.
Soriano, J.B., Sin, D.D., Zhang, X., Camp, P.G., Anderson, J.A., Anthonisen, N.R. et al. (2007) A Pooled Analysis of FEV1 Decline in COPD Patients Randomized to Inhaled Corticosteroids or Placebo. Chest131: 682-689.
89.
Szafranski, W., Cukier, A., Ramirez, A., Menga, G., Sansores, R., Nahabedian, S. et al. (2003) Efficacy and safety of budesonide/formoterol
90.
in the management of chronic obstructive pulmonary disease. Eur Resp J21: 74-81.
91.
The European Tobacco Control Report (2007) Available online at: http://www.euro.who.int/document/e89842.pdf: WHO, (retrieved 12th December 2007).
92.
Thomson, N.C. (2007a) The role of environmental tobacco smoke in the origins and progression of asthma. Curr Allergy Asthma Rep7: 303-309.
93.
Thomson, N.C. (2007b) Smokers with Asthma: What Are the Management Options ? Am J Resp Crit Care Med175: 749-750.
94.
Thomson, N.C., Chaudhuri, R. and Livingston, E. (2004) Asthma and cigarette smoking. Eur Respir J24: 822-833.
95.
Tomlinson, J.E.M., McMahon, A.D., Chaudhuri, R., Thompson, J.M.,Wood, S.F. and Thomson, N.C. (2005) Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax60: 282-287.
96.
Tsao, A.S., Liu, D., Lee, J., Spitz, M., Hong, W.K. (2006) Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer. Cancer106: 2428-2436.
97.
Tyc, V.L. and Throckmorton-Belzer, L. (2006) Smoking Rates and the State of Smoking Interventions for Children and Adolescents With Chronic Illness . Pediatrics118: e471-487.
98.
Vassallo, R., Ryu, J.H., Colby, T.V., Hartman, T. and Limper, A.H. (2000) Pulmonary Langerhans'-Cell Histiocytosis. N Engl J Med342: 1969-1978.
99.
Walker, A., O'Brien, M., Traynor, J., Fox, K., Goddard, E. and Foster, K. (2002) Living in Britain: Results from the 2001 General Household Survey, pp. 115-121. London: Office for National Statistics.
100.
Wedzicha, J.A., Calverley, P.M.A., Seemungal, T.A., Hagan, G., Ansari, Z. and Stockley, R.A. (2007) The Prevention of COPD Exacerbations by Salmeterol/Fluticasone Propionate or Tiotropium Bromide. Am J Respir Crit Care Med 200707-200973OC.
Wouters, E.F.M., Postma, D.S., Fokkens, B., Hop, W.C.J., Prins, J., Kuipers, A.F. et al. for the COSMIC (COPD and Seretide: a Multi-Center Intervention and Characterization) Study Group (2005) Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial. Thorax60: 480-487.
103.
Yang, I., Fong, K., Sim, E., Black, P. and Lasserson, T. (2007) Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews , Art. No.: CD002991. DOI: 002910.001002/14651858.CD14002991.pub14651852.
104.
Yun, S., Chanetsa, F., Kelsey, A. and Zhu, B.P. (2006) Active and passive smoking among asthmatic Missourians: Implications for health education. Prevent Med42: 286-290.
105.
Zevin, S. and Benowitz, N. (1999) Drug interactions with tobacco smoking. Clin Pharmacokinetics36: 425-438.
106.
Zheng, J.-P., Yang, L., Wu, Y.M., Chen, P., Wen, Z.G., Huang, W.J. et al. (2007) The Efficacy and Safety of Combination Salmeterol (50 mcg)/Fluticasone Propionate (500 mcg) Inhalation Twice Daily Via Accuhaler in Chinese Patients With COPD. Chest132: 1756-1763.
